Orietta Picconi
Istituto Superiore di Sanità(IT)
Publications by Year
Research Areas
Viral-associated cancers and disorders, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, HIV Research and Treatment, Multiple Sclerosis Research Studies
Most-Cited Works
- → Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure(2004)1,239 cited
- → Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study(2009)190 cited
- → Evidence for the Association of Human Papillomavirus Infection and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals(2003)119 cited
- → Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART(2010)94 cited
- → Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis(2009)92 cited
- → Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study(2013)66 cited
- → HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies(2012)57 cited
- → Quality of life, depression and fatigue in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study(2011)50 cited
- → HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial(2015)49 cited
- → The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study(2014)43 cited